Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)

• Main Authors: Jingxin Fu (Author), Kunfeng Zhang (Author), Likang Lu (Author), Manzhen Li (Author), Meihua Han (Author), Yifei Guo (Author), Xiangtao Wang (Author)
• Format: Book
• Published: MDPI AG, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cannabidiol (CBD), a nonpsychoactive major component derived from <i>Cannabis sativa</i>, widely used in neurodegenerative diseases, has now been proven to have growth inhibitory effects on many tumor cell lines, including breast tumors. Meanwhile CBD can effectively alleviate cancer-ass...